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Abstract

CHARACTERIZATION OF VANCOMYCIN RESISTANCE IN
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In the past decade, Staphylococcus aureus has developed two distinct vancomycin
resistance mechanisms. First, the bacterium is capable of generating a thickened, poorly
crosslinked cell wall that creates false targets. These targets cause vancomycin to bind at
the periphery of the thickened peptidoglycan, allowing normal cell wall formation to
continue at the cell membrane. Second, S. aureus has acquired genes from Enterococcus
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that encode an alternative stem peptide. The genes, known as van genes, alter the target of
vancomycin, rendering vancomycin treatment ineffectual.
In this work, we attempted to further characterize both mechanisms of vancomycin
resistance. First, a potential link between up-regulated purine biosynthesis and increased
vancomycin resistance due to a thickened cell wall was examined. Despite exploration of
multiple mechanisms to increase purine levels within the cell, increased purine synthesis
did not provide S. aureus with any advantage in the presence of vancomycin. However,
during the investigation, purine biosynthesis in S. aureus was further characterized by
confirming purR as the repressor of the purine pathway and demonstrating its sensitivity to
niutation.
Next, the relationship between homotypic oxacillin resistance and increased
vancomycin resistance in the absence of the van genes was investigated. Vancomycin
passage of two heterotypic methicillin resistant S. aureus (MRSA) caused these strains to
convert to homotypic oxacillin resistance in the absence of oxacillin exposure.
Additionally, conversion of heterotypic oxacillin resistant strains to homotypy by oxacillin
passage increased strain survival in vancomycin. The SOS response was examined as the
possible link between conversion to homotypic oxacillin resistance and increasing
vancomycin resistance due to a thickened cell wall. The current study, however, detected
no induction of the SOS response during vancomycin exposure.
Lastly, the relationship between oxacillin resistance and vancomycin resistance due
to the acquisition of the van genes was examined. In vitro and in vivo methods were
utilized to determine the effectiveness of a combination of p-lactam antibiotics and
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vancomycin to treat vancomycin resistant S. aureus (VRSA) infections. Combination
therapy provided a significant advantage over untreated control or either antibiotic alone in
the rabbit model of endocarditis.

